BO-011

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameBO-011
Drug Alias NameBO-011
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionEphrin-B2 inhibitorsVascular endothelial growth factor receptor 2 modulators
TargetsEphrin-B2Vascular endothelial growth factor receptor 2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHighlight Therapeutics SL
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHighlight Therapeutics SL
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A